Aids drug supply to Africa could be hit
Indian drug companies may be barred from supplying generic Aids drugs, under WHO, UN programmes, to South Africa's five million Aids suffers. Cipla and Ranbaxy, which have been working with South
Indian drug companies may be barred from supplying generic Aids drugs, under WHO, UN programmes, to South Africa's five million Aids suffers. Cipla and Ranbaxy, which have been working with South